(UPDATE) Ixazomib
Update Carfilzomib Kyprolis
Elotuzumab
(UPDATE) Daratumumab (MM)
NCCN Guidelines for Patients: Multiple Myeloma
Multiple Myeloma Research Foundation (MMRF)
NCCN COVID-19 Resources Page
ASH: COVID-19 Resources for Managing Blood Cancers